Frequently asked questions
Where are Novartis shares traded?
Novartis shares are listed and traded on the SIX Swiss Exchange (Valor No. 001200526, ISIN CH0012005267, symbol: NOVN.VX) as well as on the NYSE in the form of American Depositary Shares (ADS) (Valor No. 567514, ISIN US66987V1098, symbol: NVS).
What are the ticker symbols for Novartis?
(Reuters / Bloomberg)
(Reuters / Bloomberg)
Shares NOVN.VX ADSs NVS
What is an ADR/ADS?
ADR stands for American Depositary Receipt. ADS stands for American Depositary Share. An ADR is a receipt for a number of shares of a foreign-based corporation held in the vault of a US bank, entitling the shareholder to all dividends and capital gains.
What is the number of outstanding shares in Novartis?
Key Novartis share data
(calculated on average number of shares outstanding)
2012 2011 Issued shares 2 706 193 000 2 745 623 000 Treasury shares1 285 572 826 338 929 143 Outstanding shares at December 31 2 420 620 174 2 406 693 857 Average number of shares outstanding 2 418 145 330 2 382 461 761
- Approximately 175 million treasury shares (2011: 181 million) are held in entities that limit their availability for use.
What is the number of outstanding ADSs in Novartis?
Key data on US American Depositary Shares (ADS) issued in the US
2012 2011 Year-end ADS price (USD) 63.30 57.17 ADSs outstanding1 315 795 416 302 128 359
- The depositary, JP Morgan Chase Bank, holds one Novartis AG share for every American Depositary Share (ADS) issued.
- Where can I find historical data for Novartis shares?
- Can I deposit Novartis shares free of charge?
What is SIX SAG?
SIX SAG is an affiliate company of the SIX Group AG. Its business activities include share register and deposit administration as well as the organization and staging of shareholder meetings. For additional information, please contact:
Novartis Direct Share Purchase Plan
c/o SIX SAG Ltd
+41 62 311 61 99
+41 62 311 61 98
What is the date of your Annual General Meeting?
The Annual General Meeting took place on February 22, 2013 in Basel, Switzerland.
When is your dividend going to be paid?
The dividend payment date has been set for March 1, 2013.
What is the dividend history for Novartis shares?
The Novartis dividend has increased steadily since 1996.
The Board of Directors proposed a 2.2% increase in the dividend payment for 2012 to CHF 2.30 per share (2011: CHF 2.25), and this was approved at the Annual General Meeting on February 22, 2013. This represented the 16th consecutive increase in the dividend paid per share since the creation of Novartis in December 1996.
- How can I obtain the minutes of the last Annual General Meeting?
General Financial Questions
How do you calculate your earning per share?
Basic earnings per share (EPS) is calculated by dividing net income attributable to shareholders of Novartis AG by the weighted average number of shares outstanding in a reporting period. This calculation excludes the average number of issued shares purchased by the Group and held as treasury shares.
2012 2011 Basic earnings per share (USD) 3.93 3.83 Diluted earnings per share (USD) 3.89 3.78 Operating cash flow (USD) 5.87 6.01 Year-end equity for Novartis AG Shareholders 28.54 27.36 Dividend (CHF)2 2.30 2.25
- Calculated on average number of shares outstanding, except year-end equity per share.
- 2012: Proposal to shareholders for approval at the Annual General Meeting on February 22, 2013.
Novartis shares are widely held. As of December 31, 2012, Novartis had approximately 161 000 shareholders (2011: 165 000) listed in its share register, representing 75% of issued shares.
Based on the Novartis AG share register and excluding treasury shares, approximately 42% (2011: 43%) of the shares registered by name were held in Switzerland and 46% were held in the US (2011: 45%).
Approximately 12% of the shares registered in the share register were held by individual investors, while 88% were held by legal entities, nominees and fiduciaries.
Are there any limitations on voting rights for registered shareholders?
The Company’s Articles of Incorporation state that no person or entity shall be registered with the right to vote for more than 2% of the share capital as set forth in the Commercial Register. In particular cases the Board of Directors may allow exemptions from the limitation for registration in the share register.
According to the share register, shareholders owning 2% or more of the Company’s capital at December 31, excluding Novartis AG together with Novartis subsidiaries holding treasury shares, are as follows:
December 31, 2012 (% holding of share capital) December 31, 2011 (% holding of share capital) Novartis Foundation for Employee Participation, Basel 4.0 4.1 Emasan AG, Basel 3.3 3.2
When does the fiscal year end for Novartis?
Novartis uses the 12-month calendar year, ending December 31, as its fiscal year.
- Where can I find historical financial information about Novartis?
What is the exposure to exchange rate risk for Novartis?
Novartis transacts business in many currencies. As a result of the Group’s foreign currency exposure, exchange rate fluctuations have a significant impact on its income statement, in the form of both translation risk and transaction risk.
Translation risk is the risk that the Group’s consolidated financial statements for a particular period may be affected by changes in the prevailing rates of the various currencies of the reporting subsidiaries.
Transaction risk is the risk that the currency impact of transactions executed in currencies other than the subsidiary currency may vary according to currency fluctuations.
Recent data for selected currencies is available in our Selected exchange rate data page.
What accounting convention does Novartis follow?
The Novartis Group ("Group" or "Novartis") consolidated financial statements are prepared in accordance with the historical cost convention and comply with the standards formulated by the International Accounting Standards Board (IASB) and its predecessor organization, the International Accounting Standards Committee (IASC), and the following significant accounting policies. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual outcomes could differ from those estimates. In our quarterly earnings statements, we provide information to reconcile IAS (international) to GAAP (US) for key financial measures.
- How can I get a copy of your Annual Report?
Investor Relations Customer Services
- How can I obtain SEC documents, such as the 10-K or 20-F?
- How can I get information on your key pharmaceutical products?
- How can I get information on the dates Novartis will report sales and earnings?
Can I subscribe to receive Novartis news automatically?
We have a subscription form online where you can register to receive information. Each time something new is published on the investor relations section of our website, you will receive an alert by e-mail. Subscribe to our news
For all other investor relations-related questions
Please contact us at investor relations contacts
For all other share registry-related questions
Please contact us at share registry contact